Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
My Pioneering Excursion: Building a Startup - 2The most effective method to Go with Informed Choices on Vehicle Leases
- 3A Manual for Nations to Head out To
- 4Optimal Beauty Parlor Medicines for Upgraded Wellbeing and Appearance
- 5'The Golden Bachelor' Season 2 finale: How to watch tonight, start time, where to stream and more
- Involved Vehicles for Seniors: Track down the Best Picks for Solace and Unwavering quality
- 2024 Eurovision winner Nemo returns trophy over Israel's participation
- Discovering a sense of harmony: Individual Accounts of Reflection and Care
- 6 Popular Ladies' Aromas On the planet
- Home Machine Basics: An Exhaustive Purchasing Guide
- NASA says Maven spacecraft that was orbiting Mars has gone silent
- Favored Organic product for Seniors' Prosperity: Make Your Determination
- SUVs Known for Their Looks As opposed to Their Capacity
- Finding the Universe of Craftsmanship: Individual Encounters in Imagination
